Skip to main content
Tech.euFundingExplorerBeta

Orexa

Orexa is a clinical-stage pharmaceutical company that develops and commercialises therapeutics to increase food intake.

Orexa has raised €2.6M across 3 funding rounds, most recently a round in Feb 2024. Based in Herpen, Netherlands; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€2.6M
€2,555,000
Funding rounds
3
Investors
0
distinct backers
Active since
2022-09
latest 2024-02

Funding by year

EUR raised per year
Orexa — funding by year — interactive chart.
Data table
Orexa — funding by year
2022€1.2M
2023€485k
2024€870k

Signals

Medium confidence
Raise-next likelihood7
base rate 30% for Other
  • ▼ Past typical raise window
  • ▲ Up-round momentum
Exit likelihood8
base rate 11% (2+ rounds)
  • ▼ No recent equity round (debt-only or quiet)

Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds
DateStageAmountInvestors
2024-02-02Other€870k—View deal →
2023-01-12Other€485k—View deal →
2022-09-05Other€1.2M—View deal →

Similar companies

same sector or country

Global coverage: FundingData